| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |